Welcome to our dedicated page for Smartkem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SmartKem, Inc. filings document the public-company record for an organic semiconductor technology developer with common stock listed on Nasdaq under SMTK. The filings cover material-event reports, Securities Act registration statements, notices about annual-report timing, and disclosures tied to its advanced-materials and transistor-backplane business.
Recent regulatory documents address material definitive agreements, convertible notes, preferred stock financings, warrants, private placements, resale registration matters, Nasdaq listing-compliance disclosures, officer and subsidiary governance changes, shareholder voting matters, operating and financial results, and capital-structure updates involving common stock, preferred stock, and warrant securities.
SmartKem, Inc. reported a Q1 2026 net loss of $19.4 million, driven mainly by non-operating charges tied to an equity line of credit, derivative liabilities and debt settlement. Revenue was only $20 thousand, coming from sales of OTFT backplanes and TRUFLEX® materials.
Operating expenses fell to $2.6 million from $3.4 million a year earlier as research and development and general and administrative costs declined. After multiple equity and preferred stock financings, cash rose to $7.6 million, and stockholders’ equity turned positive at $5.4 million.
The company transferred its patent portfolio to a third party but retained process and formulation know‑how embodied in 40 trade secrets. Management states there is substantial doubt about SmartKem’s ability to continue as a going concern because current cash is not expected to fund the next 12 months, and a large equity line of credit and extensive warrants and preferred stock could significantly dilute existing shareholders.
SmartKem, Inc. is asking stockholders at its June 23, 2026 virtual annual meeting to elect two Class II directors and approve its executive pay program and say‑on‑pay frequency. Stockholders will also vote on ratifying CBIZ CPAS P.C. as auditor for the year ending December 31, 2026.
Major capital structure changes are proposed, including increasing authorized common stock from 300,000,000 to 5,000,000,000 shares, expanding the 2021 Equity Incentive Plan share pool from 1,643,692 to 2,144,622 shares, and granting the board discretion to implement up to two reverse stock splits. The company also seeks approval to issue common stock below the Nasdaq minimum price in excess of 19.99% of outstanding shares under an equity line of credit and upon conversion of Series A preferred stock and related warrants, and to amend its charter to allow stockholder action by written consent and to remove certain two‑thirds supermajority voting requirements.
The Board of SmartKem, Inc. is soliciting proxies for the virtual Annual Meeting of Stockholders to be held on (Record Date: ) for holders of Common Stock. Agenda items include election of two Class II directors, advisory votes on executive compensation and frequency, ratification of CBIZ CPAS P.C., and multiple charter and equity-related amendments.
Notable proposals: increase authorized common shares from 300,000,000 to 5,000,000,000; increase 2021 Equity Incentive Plan shares from 1,643,692 to 2,144,622; authorize up to two reverse stock split amendments; and approvals related to below‑Nasdaq‑minimum issuances tied to an Equity Line of Credit and conversion of Series A preferred/warrants.
SmartKem, Inc. funded a $2,300,000 convertible bridge loan to Ferrox Critical Minerals, earning a $200,000 origination fee and 5% annual interest until October 30, 2026. The loan is documented by a Convertible Promissory Note.
If Ferrox defaults, the interest rate increases to 15% and SmartKem becomes entitled to a $4,500-per-day default management fee. SmartKem can convert the debt into Ferrox ordinary shares at the lower of fair market value or a price based on an $80,000,000 fully‑diluted equity value.
The Note includes restrictive covenants on Ferrox’s ability to take on debt, pay dividends, or dispose of assets, and grants SmartKem a right of first refusal and exclusivity through October 30, 2026 on major equity, debt, or change‑of‑control “Fundamental Transactions.”
SmartKem, Inc. registers 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants.
The prospectus states the company is not selling any shares for its own account and will not receive proceeds from resales by the selling stockholders, although SmartKem will receive net proceeds from any warrants exercised for cash. The filing summarizes related financings including an equity line purchase agreement providing up to $500,000,000 or 19.99% of outstanding shares (whichever is less), senior secured notes with an original principal of $3,750,000 and related security interests, and a settlement involving a $300,000 cash payment and assignment of certain patents.
SmartKem, Inc. registers up to 146,776,707 shares of common stock for resale by Keystone Capital Partners, LLC under a March 30, 2026 Purchase Agreement. These shares may be issued to Keystone at the Company's discretion and then resold by Keystone. The Purchase Agreement includes a maximum committed purchase of up to $500 million or 19.99% of outstanding common stock at the time of the agreement, subject to Nasdaq limits and other conditions. The prospectus states the Company will not receive proceeds from resales by Keystone via this registration, though the Company may receive proceeds if it elects to sell shares to Keystone under the Purchase Agreement.
SmartKem, Inc. announced that a Nasdaq Hearings Panel has determined the company has regained compliance with the stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(2) and meets all other criteria for continued listing on The Nasdaq Capital Market.
The company still has until September 1, 2026 to regain compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). SmartKem will also be under a one-year Discretionary Panel Monitor, meaning any new compliance failure during this period could trigger an immediate delisting determination, though the company would be able to appeal and request a new hearing.